Pelthos Therapeutics Inc. - 8-K Filing

Pelthos Therapeutics stockholders approved the 2026 Equity Incentive Plan at its September 29 annual meeting. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 below, on September 29, 2026, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Pelthos Therapeutics Inc, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PTHS

Read the full article at SEC EDGAR

More Regulatory news